Thomas G McGuire
Overview
Explore the profile of Thomas G McGuire including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
115
Citations
2297
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Reitsma M, McGuire T, Rose S
medRxiv
. 2025 Feb;
PMID: 39974004
Importance: Payment system design creates incentives that impact healthcare spending, access, and outcomes. With Medicare Advantage accounting for more than half of Medicare spending, changes to its risk adjustment algorithm...
2.
van Kleef R, Reuser M, McGuire T, Armstrong J, Beck K, Brammli-Greenberg S, et al.
Med Care Res Rev
. 2024 Jan;
81(3):175-194.
PMID: 38284550
In health insurance markets with regulated competition, regulators face the challenge of preventing risk selection. This paper provides a framework for analyzing the scope (i.e., potential actions by insurers and...
3.
Chernew M, Carichner J, Impreso J, McWilliams J, McGuire T, Alam S, et al.
Health Aff (Millwood)
. 2021 Dec;
40(12):1909-1917.
PMID: 34871077
Claims data, which form the foundation of risk adjustment in payment for health care services, may reflect efforts to capture more-or more severe-clinical conditions rather than true changes in health...
4.
McGuire T, Zink A, Rose S
Am J Health Econ
. 2021 Dec;
7(4):497-521.
PMID: 34869790
Modifications of risk-adjustment systems used to pay health plans in individual health insurance markets typically seek to reduce selection incentives at the individual and group levels by adding variables to...
5.
Frank R, McGuire T, Nason I
Milbank Q
. 2021 Jun;
99(3):828-852.
PMID: 34075623
Context: The image of generic drugs as a commodity sold in competitive markets is an oversimplification, as evidenced by increasing accounts of price spikes, sustained high price-cost margins, and market...
6.
Baugh C, Kroshus E, Meehan 3rd W, McGuire T, Hatfield L
JAMA Netw Open
. 2020 Dec;
3(12):e2031509.
PMID: 33372973
Importance: Despite increased concern about the health consequences of contact sports, little is known about athletes' understanding of their own risk of sports-related injury. Objective: To assess whether college football...
7.
Fry C, McGuire T, Frank R
RSF
. 2020 Dec;
6(2):244-263.
PMID: 33263082
Spillovers from the Affordable Care Act Medicaid expansion to other social-sector outcomes have received little attention. One that may be especially salient for public policy is the impact of expanded...
8.
Donahoe J, McGuire T
Isr J Health Policy Res
. 2020 Nov;
9(1):68.
PMID: 33243273
In a recent issue of this Journal, Politzer, Shmueli, and Avni estimate the economic costs of health disparities due to socioeconomic status (SES) in Israel (Politzer et al., Isr J...
9.
Beck K, Kauer L, McGuire T, Schmid C
Health Policy
. 2020 Oct;
124(12):1363-1367.
PMID: 33008656
The Swiss healthcare financing system is on the verge of one of its largest reforms. The Swiss parliament is currently debating how to reallocate about 20 % of total health...
10.
McGuire T, Schillo S, van Kleef R
Eur J Health Econ
. 2020 Aug;
22(1):35-50.
PMID: 32862358
We study the extremely high and low residual spenders in individual health insurance markets in three countries. A high (low) residual spender is someone for whom the residual-spending less payment...